Controlled Substance Prescription Rules 2024. This placement is based upon the substance’s medical use, potential for abuse, and safety or dependence liability. Dea has indicated that it anticipates implementing a final set of regulations related to controlled substance prescribing via telemedicine by the fall of 2024.

Accordingly, dea, jointly with the department of health and human services (hhs), has extended current telemedicine flexibilities through december 31, 2024. In depth on october 6, 2023, the dea and samhsa issued a temporary rule that will extend.